Universal DX
Blood test for early-stage cancer detection (colon, lung, stomach, pancreas) based on epigenetics and ML. Strategic alliance with Quest Diagnostics.
Details
- Status
- Active
- Score
- 2.3
- Funding
- €178.0M
- Founded
- 2012
- Headcount
- 51-200
- City
- Sevilla